标签归档：balugrastim

Balugrastim (Synonyms: CG 10639)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Balugrastim  (Synonyms: CG 10639)

Balugrastim (CG 10639) 是一种新型的长效重组粒细胞集落刺激因子 (G-CSF)，通过重组人血清白蛋白和粒细胞集落刺激因子的遗传融合获得。Balugrastim 可用于乳腺癌的研究。

  • Balugrastim (Synonyms: CG 10639)
  • Balugrastim (Synonyms: CG 10639)

  1. Balugrastim (Synonyms: CG 10639)
  2. Balugrastim (Synonyms: CG 10639)

CAS No. : 527698-09-5

规格 是否有货
1 mg 询价
5 mg 询价

* Please select Quantity before adding items.

Balugrastim 相关产品

•同靶点产品:

•同靶点蛋白产品:

生物活性

Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer[1].

种属

Human
体内研究
(In Vivo)

Balugrastim (CG 10639) 具有很高的血浆稳定性和良好的耐受性[1]。

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial

CAS 号

527698-09-5
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Balugrastim (Synonyms: CG 10639)
    ALB (albumin, human serum albumin, HSA)25-609-CSF3 (colony stimulating factor 3, GCSF, granulocyte colony-stimulating factor, G-CSF)
纯度 & 产品资料
Data Sheet (514 KB) 抗体抑制剂使用指南 (1152 KB)

参考文献

  • [1]. Ghidini M, et al. New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim. Ther Clin Risk Manag. 2016 Jun 24;12:1009-15.  [Content Brief]

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务